UB Paderborn / Katalog / Suche / in CDI

Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes

The Journal of urology, 2007-02, Vol.177 (2), p.540

2007

Volltextzugriff (PDF)

Health-Related Quality of Life Results in Pathologic Stage C Prostate Cancer From a Southwest Oncology Group Trial Comparing Radical Prostatectomy Alone With Radical Prostatectomy Plus Radiation Therapy

Journal of clinical oncology, 2008-01, Vol.26 (1), p.112-120

2008

Volltextzugriff (PDF)

Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial

The Journal of urology, 2009-03, Vol.181 (3), p.956

2009

Volltextzugriff (PDF)

Guideline for the management of clinically localized prostate cancer: 2007 update

The Journal of urology, 2007-06, Vol.177 (6), p.2106

2007

Volltextzugriff (PDF)

Predominant Treatment Failure in Postprostatectomy Patients Is Local: Analysis of Patterns of Treatment Failure in SWOG 8794

Journal of clinical oncology, 2007-06, Vol.25 (16), p.2225-2229

2007

Volltextzugriff (PDF)

Erectile function outcome reporting after clinically localized prostate cancer treatment

The Journal of urology, 2007-08, Vol.178 (2), p.597

2007

Volltextzugriff (PDF)

The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from Southwest Oncology Group 8794

The Journal of urology, 2008-12, Vol.180 (6), p.2453

2008

Volltextzugriff (PDF)

Ten-year Follow-up of Neoadjuvant Therapy with Goserelin Acetate and Flutamide Before Radical Prostatectomy for Clinical T3 and T4 Prostate Cancer: Update on Southwest Oncology Group Study 9109

Urology (Ridgewood, N.J.), 2012-03, Vol.79 (3), p.633-637

2012

Volltextzugriff (PDF)

Retracted: Many young men with prostate‐specific antigen (PSA) screen‐detected prostate cancers may be candidates for active surveillance

BJU international, 2013-05, Vol.111 (6), p.934-940

2013

Volltextzugriff (PDF)

Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk

The Journal of urology, 2002-09, Vol.168 (3), p.1021

2002

Volltextzugriff (PDF)

Prognostic features in men who died of prostate cancer

The Journal of urology, 2005-08, Vol.174 (2), p.553

2005

Volltextzugriff (PDF)

Mechanisms of Disease: prostate cancer-a model for cancer chemoprevention in clinical practice

Nature clinical practice. Oncology, 2005-05, Vol.2 (5), p.255-261

2005

Volltextzugriff (PDF)

Fibrin sealant treatment of splenic injury during open and laparoscopic left radical nephrectomy

The Journal of urology, 2000-12, Vol.164 (6), p.2004

2000

Volltextzugriff (PDF)

Coccidioidomycosis of the epididymis and testis

American journal of roentgenology (1976), 2005-02, Vol.184 (2), p.552

2005

Volltextzugriff (PDF)

Chemoprevention of prostate cancer

Hematology/oncology clinics of North America, 2006-08, Vol.20 (4), p.831

2006

Volltextzugriff (PDF)

Chemoprevention of prostate cancer with finasteride

Expert opinion on pharmacotherapy, 2006-05, Vol.7 (7), p.899-905

2006

Volltextzugriff (PDF)

Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial

JAMA : the journal of the American Medical Association, 2006-11, Vol.296 (19), p.2329

2006

Volltextzugriff (PDF)

Prostate cancer detection strategies

Current urology reports, 2006-05, Vol.7 (3), p.181-185

2006

Volltextzugriff (PDF)

Stage Migration and Grade Inflation in Prostate Cancer: Will Rogers Meets Garrison Keillor

JNCI : Journal of the National Cancer Institute, 2005-09, Vol.97 (17), p.1236-1237

2005

Volltextzugriff (PDF)

Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated?

Current urology reports, 2005-06, Vol.6 (3), p.183-189

2005

Volltextzugriff (PDF)

External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population

Urology (Ridgewood, N.J.), 2006-12, Vol.68 (6), p.1152-1155

2006

Volltextzugriff (PDF)

Many young men with prostate-specific antigen (PSA) screen-detected prostate cancers may be candidates for active surveillance

BJU international, 2013-05, Vol.111 (6), p.934-940

2013

Volltextzugriff (PDF)

Looking Back at PCPT: Looking Forward to New Paradigms in Prostate Cancer Screening and Prevention

European urology, 2007-01, Vol.51 (1), p.27-33

2007

Volltextzugriff (PDF)

Many young men with prostate-specific antigen (PSA) screen-detected prostate cancers may be candidates for active surveillance : Urological Oncology

BJU international, 2013, Vol.111 (6), p.934-940

2013

Volltextzugriff (PDF)

Semaphorin 3B and 3F single nucleotide polymorphisms are associated with prostate cancer risk and poor prognosis

The Journal of urology, 2009-10, Vol.182 (4), p.1614

2009

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes

Health-Related Quality of Life Results in Pathologic Stage C Prostate Cancer From a Southwest Oncology Group Trial Comparing Radical Prostatectomy Alone With Radical Prostatectomy Plus Radiation Therapy

Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial

Guideline for the management of clinically localized prostate cancer: 2007 update

Predominant Treatment Failure in Postprostatectomy Patients Is Local: Analysis of Patterns of Treatment Failure in SWOG 8794

Erectile function outcome reporting after clinically localized prostate cancer treatment

The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from Southwest Oncology Group 8794

Ten-year Follow-up of Neoadjuvant Therapy with Goserelin Acetate and Flutamide Before Radical Prostatectomy for Clinical T3 and T4 Prostate Cancer: Update on Southwest Oncology Group Study 9109

Retracted: Many young men with prostate‐specific antigen (PSA) screen‐detected prostate cancers may be candidates for active surveillance

Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk

Prognostic features in men who died of prostate cancer

Mechanisms of Disease: prostate cancer-a model for cancer chemoprevention in clinical practice

Fibrin sealant treatment of splenic injury during open and laparoscopic left radical nephrectomy

Coccidioidomycosis of the epididymis and testis

Chemoprevention of prostate cancer

Chemoprevention of prostate cancer with finasteride

Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial

Prostate cancer detection strategies

Stage Migration and Grade Inflation in Prostate Cancer: Will Rogers Meets Garrison Keillor

Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated?

External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population

Many young men with prostate-specific antigen (PSA) screen-detected prostate cancers may be candidates for active surveillance

Looking Back at PCPT: Looking Forward to New Paradigms in Prostate Cancer Screening and Prevention

Many young men with prostate-specific antigen (PSA) screen-detected prostate cancers may be candidates for active surveillance : Urological Oncology

Semaphorin 3B and 3F single nucleotide polymorphisms are associated with prostate cancer risk and poor prognosis

Suchergebnisse filtern